343 related articles for article (PubMed ID: 2181268)
1. Treatment of hyperkinetic movement disorders.
Bressman SB; Greene PE
Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
[TBL] [Abstract][Full Text] [Related]
2. Case studies in movement disorders.
Evidente VG; Caviness JN; Adler CH
Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
[TBL] [Abstract][Full Text] [Related]
3. Pearls: hyperkinetic movement disorders.
Reich SG
Semin Neurol; 2010 Feb; 30(1):15-22. PubMed ID: 20127576
[TBL] [Abstract][Full Text] [Related]
4. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Chen JJ; Ondo WG; Dashtipour K; Swope DM
Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
[TBL] [Abstract][Full Text] [Related]
5. Pediatric movement disorders.
Saunders-Pullman R; Braun I; Bressman S
Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):747-65, viii. PubMed ID: 10553201
[TBL] [Abstract][Full Text] [Related]
6. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
7. Myoclonus and movement disorders.
Vercueil L
Neurophysiol Clin; 2006; 36(5-6):327-31. PubMed ID: 17336777
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment of hyperkinetic movement disorders.
Fahn S
Semin Neurol; 1987 Jun; 7(2):192-208. PubMed ID: 3332454
[No Abstract] [Full Text] [Related]
9. [Treatment of dyskinetic syndromes].
Werdelin LM; Pakkenberg H
Nord Med; 1994; 109(12):341-4. PubMed ID: 7997372
[TBL] [Abstract][Full Text] [Related]
10. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
Stahl SM; Davis KL; Berger PA
J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders in the elderly.
Gilmore R
Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615
[No Abstract] [Full Text] [Related]
12. Therapeutics of disordered movement.
Sears ES
Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of dyskinetic syndromes].
Werdelin LM; Pakkenberg H
Ugeskr Laeger; 1994 Aug; 156(34):4801-4. PubMed ID: 7992412
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
15. Movement disorders in multiple sclerosis.
Oakes PK; Srivatsal SR; Davis MY; Samii A
Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):639-51. PubMed ID: 24314682
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents.
Zesiewicz TA; Sullivan KL
Handb Clin Neurol; 2011; 100():347-63. PubMed ID: 21496594
[TBL] [Abstract][Full Text] [Related]
17. Clonidine therapy for tardive dyskinesia and related syndromes.
Nishikawa T; Tanaka M; Tsuda A; Koga I; Uchida Y
Clin Neuropharmacol; 1984; 7(3):239-45. PubMed ID: 6488198
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of movement disorders.
Marsden CD
Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955
[TBL] [Abstract][Full Text] [Related]
19. Respiratory problems in neurologic movement disorders.
Mehanna R; Jankovic J
Parkinsonism Relat Disord; 2010 Dec; 16(10):628-38. PubMed ID: 20674459
[TBL] [Abstract][Full Text] [Related]
20. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
Clark GT; Ram S
Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
